No matter whether mCAs could help to stratify persons with HC-MBL at a better risk of creating lymphoid malignancies would require investigation in larger sized cohorts. The ability to discover such people today could lay the foundation for eventually building and concentrating on interventions to potentially avert progression to frank malignancies